Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study
2008
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab
2015
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
2009 Standout
Prudent Strategies for Elective Red Blood Cell Transfusion
1992
EGFR Antagonists in Cancer Treatment
2008 Standout
Targeted therapy of thyroid cancer
2010
Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells
2011 StandoutNobel
Photodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer
2013
Thyroid cancer
2016 Standout
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 Standout
Treatment of patients with anaplastic thyroid cancer during the last 20 years: whether any progress has been made?
2014
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Changing blood use in the AIDS era: the case of elective hip surgery
1994
Nomograms in oncology: more than meets the eye
2015 Standout
Lung Cancer
2008 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions
1991
Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer
2012
Sites of erythropoietin production
1997 StandoutNobel
Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies
2010
Transfusion Medicine — Blood Transfusion
1999 Standout
Thyroid Gland Malignancies
2015
The Cost Effectiveness of Preoperative Autologous Blood Donations
1995 Standout
The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic era
2002
Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin Therapy
1989
The issues in autologous transfusion
1989
Vascular permeability factor/vascular endothelial growth factor:A multifunctional angiogenic cytokine
1997
Modifying physicians' transfusion practice
1997
3D bioprinting of tissues and organs
2014 Standout
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
2019 Standout
The pathobiology of mucositis
2004 Standout
The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*
2004 Standout
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
2014 StandoutNobel
Can tumor angiogenesis be inhibited without resistance?
2005
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Activation of apoptosis signalling pathways by reactive oxygen species
2016 Standout
Reactive oxygen species in cancer
2010 Standout
Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches
2011
Approach to the Patient with Anaplastic Thyroid Carcinoma
2012
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
TNF-related apoptosis-inducing ligand (TRAIL): A new path to anti-cancer therapies
2009
A 3D bioprinting system to produce human-scale tissue constructs with structural integrity
2016 Standout
The future of dental devices is digital
2011 Standout
Cardiac Toxicity From Systemic Cancer Therapy: A Comprehensive Review
2010
Risk of hypertension in cancer patients treated with sorafenib: an updated systematic review and meta-analysis
2013
Bioprinting of hybrid tissue constructs with tailorable mechanical properties
2011
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents
2015
Tumor Angiogenesis
2008 Standout
Hepatocellular carcinoma
2022 Standout
An Analysis of Blood Management in Patients Having a Total Hip or Knee Arthroplasty*
1999 Standout
Autologous blood transfusions
2001
Asthma
2000 Standout
The effectiveness of continuing medical education
1981
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
2012
Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer
2016
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
2000 StandoutNobel
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
A review on 3D micro-additive manufacturing technologies
2012 Standout
Autologous-blood transfusion
1992
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
2012
Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase–Rearranged Anaplastic Thyroid Carcinoma
2014
Nanoparticles in Photodynamic Therapy
2015 Standout
Markers of Response for the Antiangiogenic Agent Bevacizumab
2013
Potential Role of Platelets in Endothelial Damage Observed During Treatment With Cisplatin, Gemcitabine, and the Angiogenesis Inhibitor SU5416
2003
Effect of Repeated Whole Blood Donations on Serum Immunoreactive Erythropoietin Levels in Autologous Donors
1988
Natural product and natural product derived drugs in clinical trials
2014 Standout
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
Selecting Patients for Acute Normovolemic Hemodilution during Hepatic Resection: A Prospective Randomized Evaluation of Nomogram-Based Allocation
2013
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Improving prediction of malignancy of cytologically indeterminate thyroid nodules
2009
Emerging Targets in Photopharmacology
2016 StandoutNobel
Evidence for the Effectiveness of CME
1992 Standout
Guidelines for the management of thyroid cancer
2014 Standout
Near-infrared fluorophores for biomedical imaging
2017 Standout
Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive Malignancies
2002
Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced Cancer
2012
Vascular endothelial growth factor (VEGF) and its receptors
1999 Standout
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Works of Jay Wasman being referenced
A phase I pharmacokinetic and pharmacodynamic study of SU5416 and Adriamycin in inflammatory breast cancer
2001
Tissue‐Engineered Calcium Alginate Patches in the Repair of Chronic Chinchilla Tympanic Membrane Perforations
2006
Molecular Classification of Thyroid Nodules by Cytology
2008
Effects of Tumor Necrosis Factor and Vascular Permeability Factor on Neovascularization of the Rabbit Ear Flap
1995
Effects of a CME program on physiciansʼ transfusion practices
1989
A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with Outcome
2009
Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid
2012
Autologous Blood Donation for Elective Surgery
1987
Phase II trial of sorafenib (bay 43–9006) in patients with advanced anaplastic carcinoma of the thyroid (ATC)
2009
Novel Phase I Dose De-escalation Design Trial to Determine the Biological Modulatory Dose of the Antiangiogenic Agent SU5416
2005
A Vasculature-Targeting Regimen of Preoperative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers
2009
Inflammatory Breast Cancer as a Model Disease to Study Tumor Angiogenesis: Results of a Phase IB Trial of Combination SU5416 and Doxorubicin
2007